Evotec SE (EVO) Non-Current Deffered Revenue (2020 - 2026)
Evotec SE's (EVO) quarterly Non-Current Deffered Revenue came in at $9031.1 in Q1 2026, down 70.54% year-on-year from $30660.3 in Q1 2025, and down 7.08% quarter-over-quarter from $9719.8 in Q4 2025.
Evotec SE (EVO) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Deffered Revenue across 7 years of filings, most recently posting $9031.1 for Q1 2026.
- Non-Current Deffered Revenue for Q1 2026 came in at $9031.1, down 70.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $9031.1 (down 70.54% YoY), and the FY2025 annual result was $9719.8, down 99.97% from the prior year.
- Non-Current Deffered Revenue came in at $9031.1 for Q1 2026 at Evotec SE, down from $9719.8 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $210.3 million in Q4 2022 to a low of -$205795.8 in Q2 2022.
- The 5-year median for Non-Current Deffered Revenue is $15493.7 (2022), against an average of $34.2 million.
- Across the five-year window, Non-Current Deffered Revenue surged 449.18% in 2022 and tumbled 99.97% in 2025, its largest moves.
- Evotec SE's Non-Current Deffered Revenue stood at $210.3 million in 2022, then fell by 20.56% to $167.1 million in 2023, then sank by 80.46% to $32.7 million in 2024, then sank by 99.97% to $9719.8 in 2025, then dropped by 7.08% to $9031.1 in 2026.
- The last three Non-Current Deffered Revenue figures came in at $9031.1 (Q1 2026), $9719.8 (Q4 2025), and $10668.8 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 9,031.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,031.13 |
| Dec 31, 2025 | 9,719.76 |
| Sep 30, 2025 | 10,668.80 |
| Jun 30, 2025 | 31,697.14 |
| Mar 31, 2025 | 30,660.33 |
| Dec 31, 2024 | 32.65 Mn |
| Sep 30, 2024 | 9,569.88 |
| Dec 31, 2023 | 167.08 Mn |
| Dec 31, 2022 | 210.31 Mn |
| Sep 30, 2022 | 14,695.60 |
| Jun 30, 2022 | -205,795.75 |
| Mar 31, 2022 | 16,291.85 |
| Dec 31, 2021 | 38.30 Mn |
| Sep 30, 2021 | 21,181.18 |
| Dec 31, 2020 | 26.75 Mn |